Risk and control management of endoscopic retrograde cholangiopancreatography in patients with liver cirrhosis

VernacularTitle:肝硬化患者行经内镜逆行胰胆管造影术的风险与控制
Author: Xiaoman LI ¹ ; Lungen LU ; Xiaobo CAI
Author Information

1. 上海交通大学附属第一人民医院消化科，上海　200080
Keywords: Liver cirrhosis; Endoscopic retrograde cholangiopancreatography; Complication
From: Chinese Journal of Hepatology 2021;29(3):209-212
CountryChina
Language:Chinese
Abstract: Endoscopic retrograde cholangiopancreatography (ERCP) is the most direct and effective method for the diagnosis and treatment of biliary and pancreatic diseases. Compared with surgery, ERCP has the advantages of minimal trauma, shorter surgery time, fewer complications, and shorter hospital stay. Liver cirrhosis, as the advanced stage of liver disease, has reduced tolerance to surgical stresses, and complications such as hepatic encephalopathy, esophagogastric varices, and coagulation dysfunction may occur during the decompensated stage, which poses a challenge to ERCP, and thus increase the intraoperative risk and postoperative complications. This article reviews and discusses the indications, risk and control management of ERCP in patients with liver cirrhosis.